## Consolidated Statement of Cash Flows

**Year Ended** *(In millions, except shares and per share data)*

|  | Sep 27, 2025 | Sep 28, 2024 | Sep 30, 2023 |
| --- | --- | --- | --- |
|   Cash, cash equivalents, and restricted cash and cash equivalents, ending balances |  |  |  |
| **  Operating activities:** |  |  |  |
|     Net Income | $112,010 | $93,736 | $96,995 |
| *      Retained earnings/(Accumulated deficit)* | $112,010 | $93,736 | $96,995 |
| **    Adjustments to reconcile net income to cash generated by operating activities:** |  |  |  |
|       Depreciation and amortization | $11,698 | $11,445 | $11,519 |
|       Share-based compensation expense | $12,863 | $11,688 | $10,833 |
|       Other | $(89) | $(2,266) | $(2,227) |
| **      Changes in operating assets and liabilities:** |  |  |  |
|         Accounts receivable, net | $(6,682) | $(3,788) | $(1,688) |
|         Vendor non-trade receivables | $(347) | $(1,356) | $1,271 |
|         Inventories | $1,400 | $(1,046) | $(1,618) |
|         Other current and non-current assets | $(9,197) | $(11,731) | $(5,684) |
|         Accounts payable | $902 | $6,020 | $(1,889) |
|         Other current and non-current liabilities | $(11,076) | $15,552 | $3,031 |
|     Net Cash from Operating Activities | $111,482 | $118,254 | $110,543 |
| **  Investing activities:** |  |  |  |
|     Purchases of marketable securities | $(24,407) | $(48,656) | $(29,513) |
|     Proceeds from Maturities, Prepayments and Calls of Securities | $40,907 | $51,211 | $39,686 |
|     Proceeds from Sale of Debt Securities,  | $12,890 | $11,135 | $5,828 |
|     Payments for Property, Plant and Equipment | $(12,715) | $(9,447) | $(10,959) |
|     Other | $(1,480) | $(1,308) | $(1,337) |
|     Net Cash from Investing Activities | $15,195 | $2,935 | $3,705 |
| **  Financing activities:** |  |  |  |
|     Tax Withholding for Share-Based Compensation | $(5,960) | $(5,441) | $(5,431) |
| *      Restricted stock units* | $(6,100) | $(5,600) | $(5,600) |
|     Payments of Dividends | $(15,421) | $(15,234) | $(15,025) |
|     Repurchases of common stock | $(90,711) | $(94,949) | $(77,550) |
|     Proceeds from Issuance of Long-Term Debt | $4,481 |  | $5,228 |
|     Repayments of term debt | $(10,932) | $(9,958) | $(11,151) |
|     Proceeds from (Repayments of) Commercial Paper | $(2,032) | $3,960 | $(3,978) |
|     Other | $(111) | $(361) | $(581) |
|     Net Cash from Financing Activities | $(120,686) | $(121,983) | $(108,488) |
|   Net Change in Cash | $5,991 | $(794) | $5,760 |
|   Cash, cash equivalents, and restricted cash and cash equivalents, ending balances |  |  |  |
| **  Supplemental cash flow disclosure:** |  |  |  |
|     Income Tax Expense | $43,369 | $26,102 | $18,679 |